Rather than producing immediate or abrupt changes, semaglutide is designed to support gradual and sustained weight reduction over time when administered within a medically supervised framework
Other peptides like tesamorelin and CJC-1295/ipamorelin support weight loss through growth hormone optimization
A 2026 retrospective study in The Lancet found that postmenopausal women receiving tirzepatide alongside hormone therapy were more than four times as likely to achieve 30% weight loss compared to those on tirzepatide alone: 18% versus 4%
(13) The peptide may act indirectly by steadying the vascular setting required for new vessel growth
Early medical assessment is important because ED can be an early indicator of underlying health conditions, particularly cardiovascular disease, diabetes, or hormonal imbalances
They will consider the medications mechanism of action, dosage, and duration of use to determine if there is a connection between the medication and menstrual patterns